myeloproliferative diseases
Look at other dictionaries:
Myelodysplastic-myeloproliferative diseases — Classification and external resources MeSH D054437 Myelodysplastic myeloproliferative diseases are a category of hematological malignancies disorders created by the World Health Organization which have characteristics of both myelodysplastic and… … Wikipedia
Myeloproliferative disease — Classification and external resources ICD 10 D47.1 ICD 9 205.1 … Wikipedia
Myeloproliferative disorders — Malignant diseases of certain bone marrow cells including those that give rise to the red blood cells, the granulocytes (types of white blood cells), and the platelets (crucial to blood clotting). The myeloproliferative disorders include… … Medical dictionary
Myeloproliferative Erkrankung — Der Begriff myeloproliferative Erkrankung bzw. myeloproliferatives Syndrom (häufig „MPS“ abgekürzt, griechisch µυєλός, myelos für „Mark“, gemeint ist das Knochenmark und Prolifertion lateinisch für Vermehrung (von Zellen)) wurde 1951 von dem… … Deutsch Wikipedia
International Classification of Diseases for Oncology — The International Classification of Diseases for Oncology (ICD O) is a domain specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by… … Wikipedia
Disorders, myeloproliferative — Malignant diseases of certain bone marrow cells including those that give rise to the red blood cells, the granulocytes (types of white blood cells), and the platelets (crucial to blood clotting). The myeloproliferative disorders include… … Medical dictionary
Hydroxycarbamide — Systematic (IUPAC) name hydroxyurea … Wikipedia
Chronic myelomonocytic leukemia — Classification and external resources ICD O: M9945/3 MeSH D015477 Chronic myelomono … Wikipedia
Myeloproliferatives Syndrom — Der Begriff myeloproliferative Erkrankung bzw. myeloproliferatives Syndrom (häufig „MPS“ abgekürzt, griechisch µυєλός, myelos für „Mark“, gemeint ist das Knochenmark) wurde 1951 von dem amerikanischen Hämatologen William Dameshek geprägt[1] und… … Deutsch Wikipedia
Hydroxyurea — or hydroxycarbamide (the latter being the recommended International Nonproprietary Name) is an antineoplastic drug used in hematological malignancies, specifically polycythemia vera and essential thrombocytosis. It is also used to reduce the rate … Wikipedia
